Johnson & Johnson has offered to pay $5.5 billion to resolve thousands of lawsuits that link its talcum-based powders to ovarian cancer, a major step in one of the most closely watched product liability battles in the country. The offer would bring a measure of resolution to litigation that has dogged the company for years and drawn tens of thousands of claimants.
The dispute is not new for the drugmaker, which has been fighting accusations like these for 15 years. Over that time, the allegations surrounding its signature powders have generated waves of lawsuits and repeated courtroom clashes, making the talc litigation a defining legal challenge for one of the best-known names in consumer health products.
At the core of the lawsuits is a claim about what the products contained. The plaintiffs allege that the talcum-based powders contained cancer-causing asbestos, tying their illnesses to years of using a product marketed for everyday personal care. The asbestos allegation has been central to the cases pressing the company to account for the health of those who used its powders.
Johnson & Johnson has consistently rejected the scientific basis of the claims. The company has said there was no scientific proof to support the allegations, maintaining its position even as the litigation expanded. That stance has set up a prolonged fight between the company's account of the evidence and the claims of those who say they were harmed.
Even as it contested the lawsuits, the company changed its product. In 2020, Johnson & Johnson switched to a powder made with cornstarch instead of talc, moving away from the ingredient at the heart of the legal battle. The reformulation marked a significant shift for a product line long associated with the talc-based version now under scrutiny.
The proposed settlement is sweeping in scope, relating to about 76,000 pending claims. The sheer number of claimants underscores the scale of the litigation the company is seeking to put behind it, and the $5.5 billion figure reflects an effort to draw a line under years of lawsuits over its talcum powders as the offer moves forward.